Oarsman Capital’s Eastman Chemical EMN Stock Holding History

Oarsman Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-397	Closed	-$36.3K	–	425
2024 Q4	$36.3K	Hold	397	–	–	0.01%	501
2024 Q3	$44.4K	Buy	+397	New	+$39.7K	0.01%	474

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oarsman Capital's EMN Position: Q1 2025 in Review

Oarsman Capital sold out of Eastman Chemical (EMN) in Q1 2025, closing a stake of 397 shares — an estimated $36.3K sold.

Oarsman Capital first reported a position in EMN in Q3 2024 and held it in 2 quarters. The position peaked at $44.4K in Q3 2024. 806 funds tracked by Wall St. Rank hold EMN as of Q1 2025.

Oarsman Capital reported no remaining Eastman Chemical position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 397 Eastman Chemical shares in Q1 2025, an estimated $36.3K.
Oarsman Capital first reported a position in Eastman Chemical in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Eastman Chemical position peaked at $44.4K in Q3 2024.
806 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.